Locations:
Search
In search of optimal imaging biomarkers, best methods for long-term follow-up
Risk of new MS activity is small in those older than 55 with stable disease who stop MS therapy
$1.1M award expands follow-up to six years with focus on clinical endpoints
Mounting evidence of possible shared genetic predisposition
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Biomarker promises a practical way to reduce misdiagnoses
No notable difference in reactions with two-hour infusion in ENSEMBLE PLUS substudy
A focus on biological processes should improve both research and management
Initial pilot study findings suggest a potential reduced need for cerebrospinal fluid testing
NIH grant supports longitudinal study of clinical, cost and patient/clinician experience outcomes
Single-arm, open-label study offers proof of concept for MSC-NTF cells
Advertisement
Advertisement